Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
Status:
Recruiting
Trial end date:
2023-07-18
Target enrollment:
Participant gender:
Summary
Comparing preventive effect of myocardial global longitudinal strain-based cardioprotective
stragety (angiotensin receptor blocker prophylaxis) with left ventricular ejection
fraction-based strategy in breast cancer patients treated with adjuvant trastuzumab.